Rosita van den Puttelaar
Appearances
- DateMay 20, 2024A blood-based colorectal cancer (CRC) screening test may increase screening participation. However, blood-based screening tests may be less effective than current guideline-endorsed options…
Presenter
Speakers
Fred Hutchinson Cancer CenterOregon Health and Science UniversityMemorial Sloan Kettering Cancer Center Department of Epidemiology & BiostatisticsUniversity of Utah School of MedicineErasmus MC - DateMay 20, 2024Blood-based biomarker tests have been developed as a non-invasive colorectal cancer (CRC) screening method to triage patients to colonoscopy…
Presenter
Speakers
Memorial Sloan Kettering Cancer Center Department of Epidemiology & BiostatisticsUniversity of Utah School of MedicineErasmus MCFred Hutchinson Cancer Center - DateMay 20, 2024In 2019, a BMJ Rapid Recommendation panel judged that for adults with a predicted 15-year risk of CRC below 3%, the benefits of colorectal cancer (CRC) screening would not outweigh the burdens and potential harms. The panel recommended against CRC screening for these individuals…
- DateMay 20, 2024Prior studies showed that the benefits, harms, and costs of colorectal cancer (CRC) screening at older ages highly depend on a patient's sex, health, and screening history. However, these studies were not directly informed by stratified data on CRC risk…
